Japan’s PMDA issues GMP Certificate to Lupin’s Unit II Mandideep facility

October 09, 2019 | Wednesday | News

The PMDA inspection closed with no critical or major observations

Lupin has announced the receipt of GMP (Good Manufacturing Practice) Certificate from the Pharmaceutical and Medical Devices Agency (PMDA), Japan for its Mandideep API facility (Unit II).

The GMP Certificate was issued following an inspection conducted by PMDA between May 14, 2019 and May 17, 2019.

The PMDA inspection closed with no critical or major observations. The GMP Certificate issued by PMDA for Mandideep facility (Unit II) is valid till September 2024.

Comments

× Your session has expired. Please click here to Sign-in or Sign-up

Have an Account?

Forgot your password?

First Name should not be empty!

Last Name should not be empty!

Email address should not be empty!

Show Password should not be empty!

Show Confirm Password should not be empty!

Newsletter

E-magazine

Biospectrum Infomercial

Bio Resource

I accept the terms & conditions & Privacy policy